KLOW 80mg
KLOW is an 80mg multi-compound research blend containing TB-500 10mg, BPC-157 10mg, KPV 10mg, and GHK-Cu 50mg. Supplied as a lyophilized powder for controlled laboratory investigation of peptide interactions, cellular signaling, extracellular matrix pathways, and multi-compound analytical characterization.
Research Studies
- Investigation of multi-peptide interaction models
- Study of cellular signaling and actin-regulation pathways
- Exploration of extracellular matrix and collagen-associated mechanisms
- Evaluation of inflammatory mediator pathways in preclinical models
- Comparison of individual and combined compound activity
For laboratory research only.
Wholesale access
Apply for Wholesale AccessPricing is quoted per order under our at-will wholesale model — based on the products and volumes you need. Apply for partner access to request a quote.
KLOW is a multi-peptide blend developed for controlled laboratory workflows involving TB-500, BPC-157, KPV, and GHK-Cu. The formulation allows researchers to examine multiple peptide classes within a single, clearly disclosed composition.
Blend Composition
- TB-500: 10mg
- BPC-157: 10mg
- KPV: 10mg
- GHK-Cu: 50mg
- Total blend content: 80mg
Compound Overview
GHK-Cu is a copper-binding tripeptide examined in laboratory models involving gene expression, extracellular matrix activity, and collagen-associated signaling.
BPC-157 is a synthetic pentadecapeptide studied in preclinical models involving cellular signaling, peptide stability, and tissue-response pathways.
TB-500 is associated with thymosin beta-4 research and is examined for its interaction with actin-regulation, cellular migration, and cytoskeletal processes.
KPV is a tripeptide fragment studied in laboratory models involving melanocortin-associated signaling and inflammatory mediator activity.
Key Research Areas
- Multi-compound peptide characterization
- Peptide interaction and comparative-response models
- Actin dynamics and cytoskeletal signaling
- Extracellular matrix and collagen-associated pathways
- Cellular migration and tissue-response mechanisms
- Inflammatory mediator and melanocortin-related signaling
- Copper-peptide coordination and analytical review
Research Context
Preclinical and in-vitro literature examines the individual components of KLOW across distinct cellular and molecular pathways. The combined formulation may be used to evaluate component interactions, concentration relationships, analytical composition, and differences between individual-compound and multi-compound research models.
References to tissue response, regeneration, inflammation, collagen, cellular migration, or related pathways describe laboratory research areas only. They do not indicate medical, therapeutic, cosmetic, performance, or human-use outcomes.
For laboratory and in-vitro research only. Educational reference only.
| Goal | |
|---|---|
| Strength | 80mg |
| Count/Size | 5mL Vial |





